MedPath

A Randomised Study for effect of treatment on Quantitative Electroencephalogram in persons with Alcohol Dependence Syndrome

Phase 4
Conditions
Health Condition 1: H- Substance Abuse Treatment
Registration Number
CTRI/2023/09/057998
Lead Sponsor
Government Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients diagnosed with Alcohol Dependence Syndrome as per ICD-11 criteria.

2. Alcohol withdrawal assessment scoring guidelines (CIWA-AR) score <15. (mild to

moderate withdrawals as per Maudsley guidelines)

3. Age groups 25 and above.

4. Male gender.

Exclusion Criteria

1. Patients who are known cases of epilepsy.

2. Patient dependent on other substances except nicotine and caffeine

3. Patients with past history of complicated withdrawals

4. Patients who are intoxicated or are in severe withdrawals.

5. Patients with comorbid active psychotic illness.

6. Actively suicidal patients.

7. Patients with any acute medical or surgical illness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
se of Quantitative Electroencephalogram as screening and diagnostic tool for alcohol use disorder.Timepoint: 1. At baseline <br/ ><br>2. After completion of detoxification (CIWA-Ar <8) <br/ ><br>3. After 3 months
Secondary Outcome Measures
NameTimeMethod
Comparison and assessment of anxiety and depression from baseline by using scales - HAM-A, HAM-D.Timepoint: 1. At baseline <br/ ><br>2. After completion of detoxification (CIWA-Ar <8) <br/ ><br>3. After 3 months;Comparison of Lorazepam and Diazepam with reference to changes in Quantitative Electroencephalogram along with objective scale scores on SADQ and CIWA-Ar.Timepoint: 1. At baseline <br/ ><br>2. After completion of detoxification (CIWA-Ar <8) <br/ ><br>3. After 3 months
© Copyright 2025. All Rights Reserved by MedPath